Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
bioMerieux S.A.

Start price
Target price
Perf. (%)
€111.90
12.04.21
€120.00
12.04.22
-3.84%
07.11.21

Could be worthwhile Investment >10% per year
buy
Euromedis Groupe

Start price
Target price
Perf. (%)
€22.15
12.04.21
€28.35
12.04.22
-51.96%
24.12.21

Could be worthwhile Investment >10% per year
buy
Vivani Medical Inc.

Start price
Target price
Perf. (%)
€24.60
06.04.21
-
06.04.22
-34.15%
03.05.21

Good rating
Capable Management
Probably not worthwhile Investment
No Innovation
buy
Adverum Biotechnologies Inc.

Start price
Target price
Perf. (%)
€8.60
06.04.21
€10.00
06.04.22
-15.12%
19.04.21

Could be worthwhile Investment >10% per year
buy
Epizyme Inc.

Start price
Target price
Perf. (%)
€7.47
06.04.21
€9.00
06.04.22
-9.64%
19.04.21

Could be worthwhile Investment >10% per year
buy
Aravive, Inc.

Start price
Target price
Perf. (%)
€4.90
06.04.21
€6.00
06.04.22
-10.20%
19.04.21

Could be worthwhile Investment >10% per year
buy
Molecular Templates Inc.

Start price
Target price
Perf. (%)
€7.65
06.04.21
€9.00
06.04.22
-12.68%
19.04.21

Could be very worthwhile Investment >20% year
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€56.02
06.04.21
€60.00
06.04.22
3.82%
01.07.21

Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
buy
Matinas BioPharma Holdings Inc

Start price
Target price
Perf. (%)
€0.93
06.04.21
€2.00
06.04.22
-25.41%
19.04.21

Could be worthwhile Investment >10% per year
buy
Organovo Holdings Inc.

Start price
Target price
Perf. (%)
€8.35
06.04.21
€10.00
06.04.22
-13.30%
19.04.21

Could be worthwhile Investment >10% per year
buy
Intellia Therapeutics Inc

Start price
Target price
Perf. (%)
€69.62
06.04.21
€80.00
06.04.22
-17.38%
19.04.21

Could be worthwhile Investment >10% per year
buy
WAVE Life Sciences Ltd

Start price
Target price
Perf. (%)
€5.59
06.04.21
€7.00
06.04.22
-8.23%
19.04.21

Could be very worthwhile Investment >20% year
buy
Biofrontera AG

Start price
Target price
Perf. (%)
€2.47
06.04.21
-
06.04.24
-84.62%
11.03.24

Could be worthwhile Investment >10% per year
buy
Teladoc Health Inc

Start price
Target price
Perf. (%)
€158.00
04.04.21
€75.00
04.04.22
-56.02%
05.04.22

Could be worthwhile Investment >10% per year
Higher EBIT margin than peer group
Good rating
ROE higher than 10% per year
buy
WAVE Life Sciences Ltd

Start price
Target price
Perf. (%)
€4.22
30.03.21
-
30.03.22
25.59%
01.04.21

Probably not worthwhile Investment
Merck KGaA

Start price
Target price
Perf. (%)
€144.40
25.03.21
€130.00
25.03.22
56.79%
14.12.21

Some uniques
Future proof or reliable business model
overvalued
Low dividend yield expected
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€152.98
25.03.21
€140.00
25.09.21
25.83%
28.06.21

Could be worthwhile Investment >10% per year
Known brand
Medium risks for its business
overvalued
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€136.62
24.03.21
€145.00
24.03.22
-1.26%
09.04.21

Known brand
Future proof or reliable business model
Medium risks for its business
buy
Organovo Holdings Inc.

Start price
Target price
Perf. (%)
€8.12
24.03.21
€10.00
24.03.22
2.77%
06.04.21

Could be worthwhile Investment >10% per year
buy
VBI Vaccines Inc.

Start price
Target price
Perf. (%)
€82.08
24.03.21
€120.00
24.03.22
-5.19%
06.04.21

Could be worthwhile Investment >10% per year
buy
Intellia Therapeutics Inc

Start price
Target price
Perf. (%)
€53.20
24.03.21
€60.00
24.03.22
30.86%
06.04.21

Could be worthwhile Investment >10% per year
buy
WAVE Life Sciences Ltd

Start price
Target price
Perf. (%)
€6.50
24.03.21
€9.00
24.03.22
-14.00%
06.04.21

Could be very worthwhile Investment >20% year
buy
Benitec Biopharma Inc.

Start price
Target price
Perf. (%)
€5.50
23.03.21
€8.00
23.03.22
-18.55%
03.04.21

Could be worthwhile Investment >10% per year
Capable Management
Bad culture
buy
Palisade Bio Inc.

Start price
Target price
Perf. (%)
€564.00
22.03.21
€900.00
22.03.22
-17.45%
03.04.21

Good culture
Capable Management
Could be worthwhile Investment >10% per year
Few uniques
buy
Gritstone Oncology Inc

Start price
Target price
Perf. (%)
€11.50
21.03.21
-
21.03.22
-64.30%
22.03.22

Could be very worthwhile Investment >20% year
Innovative